Jonathan Wills

5.1k total citations
29 papers, 1.1k citations indexed

About

Jonathan Wills is a scholar working on Internal Medicine, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jonathan Wills has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Internal Medicine, 8 papers in Neurology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jonathan Wills's work include Venous Thromboembolism Diagnosis and Management (11 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Jonathan Wills is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Jonathan Wills collaborates with scholars based in United States, Switzerland and Canada. Jonathan Wills's co-authors include Anita Sidhu, Valeriy Duka, Joel J. Credle, Adam W. Oaks, Jessica M. Jones, Simon Mantha, Gerald A. Soff, Jeffrey N. Joyce, Yimei Miao and Rekha Parameswaran and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jonathan Wills

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Wills United States 17 394 240 207 164 163 29 1.1k
Feng Liang China 14 167 0.4× 96 0.4× 62 0.3× 250 1.5× 100 0.6× 41 829
W R Timperley United Kingdom 12 182 0.5× 189 0.8× 42 0.2× 97 0.6× 127 0.8× 17 759
Dolors Giralt Spain 22 188 0.5× 67 0.3× 46 0.2× 418 2.5× 147 0.9× 46 1.2k
B. McArdle United Kingdom 19 53 0.1× 114 0.5× 111 0.5× 279 1.7× 203 1.2× 39 963
Albert K.Y. Tsui Canada 19 140 0.4× 112 0.5× 20 0.1× 207 1.3× 155 1.0× 39 858
Aída Lago Spain 15 260 0.7× 70 0.3× 157 0.8× 141 0.9× 299 1.8× 50 1.0k
Zilong Zhao China 18 398 1.0× 39 0.2× 36 0.2× 551 3.4× 36 0.2× 50 1.1k
Mariko Kajikawa Japan 18 33 0.1× 82 0.3× 540 2.6× 354 2.2× 892 5.5× 36 1.8k
Akio Kuroiwa Japan 18 108 0.3× 159 0.7× 12 0.1× 260 1.6× 406 2.5× 91 1.0k

Countries citing papers authored by Jonathan Wills

Since Specialization
Citations

This map shows the geographic impact of Jonathan Wills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Wills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Wills more than expected).

Fields of papers citing papers by Jonathan Wills

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Wills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Wills. The network helps show where Jonathan Wills may publish in the future.

Co-authorship network of co-authors of Jonathan Wills

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Wills. A scholar is included among the top collaborators of Jonathan Wills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Wills. Jonathan Wills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mulcahy, Mary F., Halla Nimeiri, Osama E. Rahma, et al.. (2023). Real-world outcome analysis of patients with advanced gastric and gastroesophageal adenocarcinoma with HER2-low expression treated with first-line therapy.. Journal of Clinical Oncology. 41(4_suppl). 326–326. 2 indexed citations
2.
Dunbar, Andrew, Kelly L. Bolton, Sean M. Devlin, et al.. (2020). Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors. Blood. 137(15). 2103–2113. 66 indexed citations
3.
Soff, Gerald A., Jodi V. Mones, Sean M. Devlin, et al.. (2019). Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience. Research and Practice in Thrombosis and Haemostasis. 3(3). 349–356. 22 indexed citations
4.
Isenberg‐Grzeda, Elie, et al.. (2018). Antidepressants appear safe in patients with carcinoid tumor: Results of a retrospective review. European Journal of Surgical Oncology. 44(6). 744–749. 8 indexed citations
5.
6.
Mantha, Simon, Yimei Miao, Jonathan Wills, Rekha Parameswaran, & Gerald A. Soff. (2017). Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study. Journal of Thrombosis and Thrombolysis. 43(4). 514–518. 58 indexed citations
7.
Ulaner, Gary A., et al.. (2017). 18F–FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 44(9). 1420–1427. 45 indexed citations
8.
Yu, Anthony F., Dipti Gupta, Yimei Miao, et al.. (2017). Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer. The American Journal of Cardiology. 120(2). 213–217. 34 indexed citations
9.
Pickup, Kathryn, Scott Martin, E. A. Partridge, et al.. (2016). Acute liver effects, disposition and metabolic fate of [14C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice. Archives of Toxicology. 91(7). 2643–2653. 3 indexed citations
10.
Ulaner, Gary A., Debra A. Goldman, Jonathan Wills, et al.. (2016). 18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 43(11). 1937–1944. 56 indexed citations
11.
Mantha, Simon, Yimei Miao, Debra Sarasohn, et al.. (2016). Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study. Journal of Thrombosis and Thrombolysis. 43(2). 166–171. 73 indexed citations
12.
Credle, Joel J., Patrick A. Forcelli, Michael Delannoy, et al.. (2015). α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. Neurobiology of Disease. 76. 112–125. 85 indexed citations
13.
Mantha, Simon, Yimei Miao, Debra Sarasohn, et al.. (2015). Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative. Blood. 126(23). 431–431. 2 indexed citations
14.
Pickup, Kathryn, Jonathan Wills, Huw B. Jones, et al.. (2013). The metabolic fate of [14C]-fenclozic acid in the hepatic reductase null (HRN) mouse. Xenobiotica. 44(2). 164–173. 8 indexed citations
15.
Wills, Jonathan, Joel J. Credle, Adam W. Oaks, et al.. (2012). Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways. PLoS ONE. 7(1). e30745–e30745. 85 indexed citations
16.
Wills, Jonathan, et al.. (2011). Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease. PLoS ONE. 6(3). e17953–e17953. 63 indexed citations
17.
Credle, Joel J., Olga Rodriguez, Jonathan Wills, et al.. (2011). Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease. European Journal of Neuroscience. 33(9). 1598–1610. 102 indexed citations
18.
Wills, Jonathan, et al.. (2010). Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Experimental Neurology. 225(1). 210–218. 166 indexed citations
19.
Derlet, Robert W., et al.. (2006). Ambulance diversion reduction: the Sacramento solution. The American Journal of Emergency Medicine. 24(2). 206–213. 37 indexed citations
20.
Wills, Jonathan. (2000). Muddied Waters A Survey of Offshore Oilfield Drilling Wastes and Disposal Techniques to Reduce the Ecological Impact of Sea Dumping. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Liang Breakdown of academic impact, for papers by W R Timperley Breakdown of academic impact, for papers by Dolors Giralt Breakdown of academic impact, for papers by B. McArdle Breakdown of academic impact, for papers by Albert K.Y. Tsui Breakdown of academic impact, for papers by Aída Lago Breakdown of academic impact, for papers by Zilong Zhao Breakdown of academic impact, for papers by Mariko Kajikawa Breakdown of academic impact, for papers by Akio Kuroiwa
Rankless by CCL
2026